期刊
CANCER CELL
卷 36, 期 6, 页码 582-596出版社
CELL PRESS
DOI: 10.1016/j.ccell.2019.10.007
关键词
-
资金
- NIH [NS103740, NS065957]
- Sigrid Juselius Foundation
Adenosine is a key metabolic and immune-checkpoint regulator implicated in the tumor escape from the host immune system. Major gaps in knowledge that impede the development of effective adenosine-based therapeutics include: (1) lack of consideration of redundant path rays controlling ATP and adenosine levels; (2) lack of distinction between receptor-dependent and -independent effects of adenosine, and (3) focus on extracellular adenosine without consideration of intracellular metabolism and compartmentalization. In light of current clinical trials, we provide an overview of adenosine metabolism and mint out the need for a more careful evalution of the entire purinome in emerging cancer therapies.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据